2016 Review: Despite Political Woes, Korea Pro-Pharma Policies Stay Intact
Executive Summary
2016 has been full of shock and despair in South Korea’s political scene. But when it comes to the country’s biopharma policy, the year has seen fewer surprising or dramatic events.